CAMERON POLE, M.D.
Ophthalmology Physician · LOS ANGELES, CA
Individual Active NPI 1386090074
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,643 | 51,780 | $14,381,380 | $5,180,721 | $4,082,109 |
| 2023 | 2,195 | 47,924 | $16,031,625 | $5,901,525 | $4,633,832 |
| 2022 | 954 | 5,512 | $3,396,164 | $1,191,484 | $946,784 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 34,500 | $34 | $27 |
| 92134 | Imaging of retina | 3,321 | $44 | $33 |
| J0177 | Injection, aflibercept hd, 1 mg | 3,096 | $332 | $264 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 1,961 | $224 | $178 |
| 67028 | Injection of drug into eye | 1,939 | $135 | $101 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 1,260 | $147 | $117 |
| J0178 | Injection, aflibercept, 1 mg | 1,182 | $823 | $654 |
| 92012 | Established patient problem focused exam of visual system | 721 | $98 | $71 |
| 92014 | Established patient complete exam of visual system | 715 | $139 | $102 |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 570 | $171 | $136 |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 315 | $185 | $144 |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 273 | $202 | $161 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | A151860 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in California
- NPI 1962412643
- NPI 1679758544
- NPI 1992992945
- NPI 1073816070
- NPI 1942369699
- NPI 1295000693
- NPI 1073730081
- NPI 1801390216
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.